Richard William Scalzo
Chief Financial Officer · 2 filings · Latest: Sep 16, 2026
CRESCENT BIOPHARMA, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CBIO | Richard William Scalzo | Chief Financial Officer | Sep 16, 2026 | Sale | $17.90 | 568 | $10.2K | 19,730 | |
CBIO | Richard William Scalzo | Chief Financial Officer | Jun 22, 2026 | Sale | $17.99 | 1,112 | $20.0K | 20,298 | |
DYN | Scalzo Richard William | — | Jun 11, 2025 | Proposed Sale | $14.75 | 1,330 | $19.6K | — | |
DYN | Scalzo Richard William | — | Jun 5, 2025 | Proposed Sale | $13.35 | 914 | $12.2K | — | |
DYN | Scalzo Richard William | — | May 16, 2025 | Proposed Sale | $11.82 | 2,479 | $29.3K | — | |
DYN | Scalzo Richard William | — | Mar 11, 2025 | Proposed Sale | $11.38 | 1,343 | $15.3K | — | |
DYN | Scalzo Richard William | — | Mar 5, 2025 | Proposed Sale | $11.89 | 915 | $10.9K | — | |
DYN | Scalzo Richard William | — | Feb 18, 2025 | Proposed Sale | $13.91 | 2,488 | $34.6K | — | |
DYN | Scalzo Richard William | — | Dec 11, 2024 | Proposed Sale | $28.33 | 1,455 | $41.2K | — | |
DYN | Scalzo Richard William | — | Nov 18, 2024 | Proposed Sale | $28.39 | 2,735 | $77.6K | — | |
DYN | Scalzo Richard William | — | Sep 18, 2024 | Proposed Sale | $34.51 | 1,390 | $48.0K | — | |
DYN | Scalzo Richard William | — | Sep 11, 2024 | Proposed Sale | $32.43 | 1,468 | $47.6K | — | |
DYN | Scalzo Richard William | — | Aug 19, 2024 | Proposed Sale | $33.65 | 126,073 | $4.2M | — |